The medicinal products mentioned in II and III of article L. 5124-8 are manufactured in accordance with the good practices provided for in article L. 5138-3, subject to adaptations made necessary by specific defence requirements and having received the assent of the Agence nationale de sécurité du médicament et des produits de santé.